T/F? Bone density is recommended in all women 2 years post-menopause. - answer
FALSE
-Baseline 65years and older
A 52-year-old woman presents with amenorrhea for one year and moderate hot flashes
for 6 months. She is interested in bioidentical hormone relief for her hot flashes and
wants to know if they are better for her than other hormones. Appropriate info to provide
would be, what? - answer17 beta-estradiol is a bioidentical form of estrogen available in
oral, transdermal, and vaginal formulations
Which of the following statements concerning the estrogen agonist/antagonist raloxifine
(Evista) is correct? - answerIt is approved for the prevention and treatment of
osteoporosis.
T/F? Data supports the use of topically applied progesterone creams for endometrial
protection in menopausal women taking estrogen. - answer FALSE
What would NOT be an expected finding in a pelvic examination of a 70-year-old
woman? - answerOvaries easily palpable
A menopausal woman experiencing discomfort with sexual intercourse related to
vaginal dryness wants to know whether she should use a vaginal lubricant or a vaginal
moisturizer. What would NOT be a true statement?
a. Lubricants are intended to reduce friction r/t sex
b. Lubricants can take several weeks of use before becoming effective
c. Moisturizers provide long-term relief of vaginal dryness than lubricants
d. Moisturizers are typically applied several times weekly - answerB. Effective
immediately
T/F? Data supports the use of hormonal therapy for prevention of cognitive decline if
started soon after menopause. - answerFALSE
An advantage of the transdermal patch over oral delivery of estrogen for women
experiencing menopausal symptoms is that the transdermal delivery
method_____________________. - answerHas less adverse effects on coagulation
factors
In one to two years postmenopausal women, you would expect the following hormone
level changes when compared with premenopausal women. - answerIncreased FSH,
decreased ani-mullerian hormone, decreased estradiol